1. Global Tuberculosis Report 2017,2017
2. Principes directeurs à l’intention des programmes antituberculeux pour la prise en charge des tuberculoses pharmacorésistantes,2009
3. Guidelines for clinical and operational management of drug-resistant tuberculosis;Perrin,2013
4. Aminoglycoside-induced ototoxicity;Selimoglu;Curr Pharm Des,2007
5. Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis;Prasad;Indian J Tuberc,2016